In partnership with three Thai state-owned organisations, CSIRO’s Biomedical Manufacturing team is improving Thailand’s capacity to manufacture essential drugs and improve local and equitable access to medicines. Project activities include trainings at CSIRO’s state-of-the-art facilities in Victoria, Australia where project partners are supported to perform end-to-end process development work on drugs selected by the Thai partners based on national priorities.
The BPM_TEAM project focuses on two biomedical areas: 1) biologic drug development using the Chinese Hamster Ovary cell platform; and 2) small molecule active pharmaceutical ingredient drug development using green chemistry principles and continuous flow processing.
At the successful completion of this project, Thai state-owned organisations will have the knowledge, processes and frameworks to industrialise the country’s biotech manufacturing industry, strengthening the country and the region’s preparedness against health emergencies and improve Thai citizens’ health outcomes.
